ホーム > 市場調査レポート > 医薬品

市場調査レポート

商品コード

1098621

タクロリムスの市場規模・シェア・展望・機会 (2022年～2030年)：製品タイプ・用途・エンドユーザー・地域別

Tacrolimus Market, by Product Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日: 2022年06月10日 | 発行: Coherent Market Insights

| ページ情報: 英文 190 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 699,570円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,088,220円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,554,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.46円

全表示
概要
目次

概要

サンプル依頼リストに入れる

主要企業による製品上市の増加が予測期間中の世界のタクロリムス市場の成長を促進すると予想されます。また、主要企業は、タクロリムス製品の流通など、無機的成長戦略に注力しており、このことも予測期間中の市場成長を促進するものと考えられています。

当レポートでは、世界のタクロリムスの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、法規制・償還環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

Tacrolimus is a calcineurin inhibitor and potent immunosuppressive drug that is primarily used to prevent cellular rejection following organ transplantation. It is also used topically to treat severe atopic dermatitis, severe refractory uveitis following bone marrow transplants, and the skin disorder vitiligo. Tacrolimus is available in capsule, granules for oral suspension (to be combined with liquid), extended-release (long acting) capsule, and extended-release tablet for oral administration. Tacrolimus immediate-release formulations, in combination with other immunosuppressants, are approved for the prevention of organ rejection in adult and pediatric patients receiving allogeneic liver, kidney, heart, or lung transplants. Tacrolimus extended-release formulations are approved for the prevention of organ rejection in adult and pediatric patients having kidney transplants when combined with other immunosuppressants, and may be used in patients who have been converted from immediate-release formulations.

Market Dynamics

The increasing product launch by the key players in the market is expected to drive the market growth over the forecast period. For instance, in June 2020, Sandoz, a Novartis division and a global leader in generic pharmaceuticals and biosimilars, announced the launch of once-daily generic tacrolimus capsules known as Dailiport in Germany, the U.K., The Netherlands, Finland, Sweden, Estonia, Latvia, and Slovakia, and as Conferoport in Italy and Spain.

Moreover, key companies in the market are focusing on inorganic growth strategies such as distribution of tacrolimus products, which is expected to drive the market growth over the forecast period. For instance, in January 2022, Mayne Pharma Group Limited, an Australia-based specialty pharmaceutical company announced that it had begun distribution of tacrolimus ointment, 0.1% in the U.S. Tacrolimus ointment is a generic version of PROTOPIC, indicated for the treatment of Atopic dermatitis.

Key features of the study:

This report provides an in-depth analysis of the global tacrolimus market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global tacrolimus market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novartis AG, Mylan N.V., Astellas Pharma Inc., Dr. Reddy's Laboratories Ltd., Pfizer Inc., Abbott, Senju Pharmaceutical Co. Ltd., Glenmark Pharmaceuticals Ltd., Lupin Limited, and Vibcare Pharma Pvt. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global tacrolimus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tacrolimus market

Detailed Segmentation:

Global Tacrolimus Market, By Product Type:
- Tacrolimus Capsules and Tablets
- Tacrolimus Ointment
- Tacrolimus Injection
- Tacrolimus Granules
Global Tacrolimus Market, By Application:
- Immunosuppression
- Dermatitis
- Others
Global Tacrolimus Market, By End User:
- Organ Transplant Centers
- Hospitals
- Clinics
- Others
Global Tacrolimus Market, By Region:
- North America
  - By Country
  - U.S.
  - Canada
- Latin America
  - By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Country
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Country
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Region/Country
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Novartis AG
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Mylan N.V.
- Astellas Pharma Inc.
- Reddy's Laboratories Ltd.
- Pfizer Inc.
- Abbott
- Senju Pharmaceutical Co. Ltd.
- Glenmark Pharmaceuticals Ltd.
- Lupin Limited
- Vibcare Pharma Pvt. Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Epidemiology
Regulatory Scenario
PEST Analysis
Reimbursement Analysis
Pricing Analysis
New Product Approval/Launch
Substitutes/Alternatives of Tacrolimus

4. Global Tacrolimus Market - Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Demand and Supply Analysis

5. Global Tacrolimus Market, By Product Type, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Tacrolimus Capsules and Tablets
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Tacrolimus Ointment
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Tacrolimus Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Tacrolimus Granules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Tacrolimus Market, By Application, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Immunosuppression
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Dermatitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Tacrolimus Market, By End User, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Organ Transplant Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Tacrolimus Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa

9. Competitive Landscape

Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Dr. Reddy's Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Senju Pharmaceutical Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Glenmark Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lupin Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Vibcare Pharma Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About Us

ライセンス / 価格

PDF (Single User License)

USD 4,500 699,570円

PDF (Multi User License)

USD 7,000 1,088,220円

PDF (Enterprise User License)

USD 10,000 1,554,600円

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.46円

お電話でのお問い合わせ

044-952-0102

( 土日・祝日を除く )

タクロリムス

タクロリムスの市場規模・シェア・展望・機会 (2022年～2030年)：製品タイプ・用途・エンドユーザー・地域別

Tacrolimus Market, by Product Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

目次

第1章調査目的・前提条件

第2章市場概要

第3章市場力学・規制・動向分析

第4章世界のタクロリムス市場：COVID-19の影響

第5章世界のタクロリムス市場：製品タイプ別

第6章世界のタクロリムス市場：用途別

第7章世界のタクロリムス市場：エンドユーザー別

第8章世界のタクロリムス市場：地域別

第9章競合情勢

第10章セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Tacrolimus Market - Impact of Coronavirus (Covid-19) Pandemic

5. Global Tacrolimus Market, By Product Type, 2017 - 2030, (US$ Million)

6. Global Tacrolimus Market, By Application, 2017 - 2030, (US$ Million)

7. Global Tacrolimus Market, By End User, 2017 - 2030, (US$ Million)

8. Global Tacrolimus Market, By Region, 2017 - 2030, (US$ Million)

9. Competitive Landscape

10. Section

タクロリムスの市場規模・シェア・展望・機会 (2022年～2030年)：製品タイプ・用途・エンドユーザー・地域別

Tacrolimus Market, by Product Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

目次

第1章 調査目的・前提条件

第2章 市場概要

第3章 市場力学・規制・動向分析

第4章 世界のタクロリムス市場：COVID-19の影響

第5章 世界のタクロリムス市場：製品タイプ別

第6章 世界のタクロリムス市場：用途別

第7章 世界のタクロリムス市場：エンドユーザー別

第8章 世界のタクロリムス市場：地域別

第9章 競合情勢

第10章 セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Tacrolimus Market - Impact of Coronavirus (Covid-19) Pandemic

5. Global Tacrolimus Market, By Product Type, 2017 - 2030, (US$ Million)

6. Global Tacrolimus Market, By Application, 2017 - 2030, (US$ Million)

7. Global Tacrolimus Market, By End User, 2017 - 2030, (US$ Million)

8. Global Tacrolimus Market, By Region, 2017 - 2030, (US$ Million)

9. Competitive Landscape

10. Section

第1章調査目的・前提条件

第2章市場概要

第3章市場力学・規制・動向分析

第4章世界のタクロリムス市場：COVID-19の影響

第5章世界のタクロリムス市場：製品タイプ別

第6章世界のタクロリムス市場：用途別

第7章世界のタクロリムス市場：エンドユーザー別

第8章世界のタクロリムス市場：地域別

第9章競合情勢

第10章セクション